Phase II Trial of the CDK4 Inhibitor PD0332991 in Patients With Advanced CDK4-Amplified Well-Differentiated or Dedifferentiated Liposarcoma

✍ Scribed by Dickson, M. A.; Tap, W. D.; Keohan, M. L.; D'Angelo, S. P.; Gounder, M. M.; Antonescu, C. R.; Landa, J.; Qin, L.-X.; Rathbone, D. D.; Condy, M. M.; Ustoyev, Y.; Crago, A. M.; Singer, S.; Schwartz, G. K.

• Book ID: 121342776
• Publisher: American Society of Clinical Oncology
• Year: 2013
• Tongue: English
• Weight: 638 KB
• Volume: 31
• Category: Article
• ISSN: 0732-183X
• DOI: 10.1200/JCO.2012.46.5476